Genmab A/S
AXL ANTIBODY-DRUG CONJUGATES FOR USE IN TREATING CANCER
Last updated:
Abstract:
The present invention relates to conjugates of antibodies and cytotoxic agents for use in treatment of cancer in combination with an inhibitor of PD-1 or PD-L1. The antibodies are directed against Axl.
Status:
Application
Type:
Utility
Filling date:
17 Jul 2020
Issue date:
1 Sep 2022